Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myc confers androgen-independent prostate cancer cell growth

1 Dec 2003

Abstract excerpt

Prostate cancer is one of the most diagnosed and mortal cancers in western countries. A major clinical problem is the development of androgen-independent prostate cancer (AIPC) during antihormonal treatment. The molecular mechanisms underlying the change from androgen dependence to independence of these tumors are poorly understood and represent a challenge to develop new therapies. Based on genetic data showing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Prostate Cancer Treatment and Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14660748
DOI: 10.1172/jci19035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myc confers androgen-independent prostate cancer cell growthPMID 14660748Read ↗

Myc confers androgen-independent prostate cancer cell growthSemantic proximity Read ↗

c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene NetworksSemantic proximity Read ↗

Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell LineSemantic proximity Read ↗

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsSemantic proximity Read ↗

Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.Semantic proximity Read ↗

Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.Semantic proximity Read ↗

A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistanceSemantic proximity Read ↗

Myc-driven murine prostate cancer shares molecular features with human prostate tumorsSemantic proximity Read ↗

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsSemantic proximity Read ↗

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.Semantic proximity Read ↗

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.Semantic proximity Read ↗

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.